Bala, Rebecca D.

HRN: 20-22-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
CEFUROXIME 1.5GM (VIAL)
02/06/2023
02/12/2023
IV
1.5gm
Q8
UTI
02/06/2023
CEFTAZIDIME 1GM (VIAL)
02/06/2023
02/12/2023
IV
1gm
Q8
Complicated Uti
Waiting Final Action 
03/03/2023
CEFTAZIDIME 1GM (VIAL)
03/03/2023
03/10/2023
IV
2g
OD
UTI
03/03/2023
CEFTRIAXONE 1G (VIAL)
03/03/2023
03/10/2023
IV
2g
OD
UTI
Waiting Final Action 
03/06/2023
CIPROFLOXACIN 500MG (TAB)
03/06/2023
03/13/2023
PO
500mg
BID
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: